{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:40Z","timestamp":1791639160319,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["149094"],"award-info":[{"award-number":["149094"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["505297"],"award-info":[{"award-number":["505297"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["21A0"],"award-info":[{"award-number":["21A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.healun.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:49:28Z","timestamp":1679543368000},"page":"1152-1160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6368-8015","authenticated-orcid":false,"given":"Liran","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Moshkelgosha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Huszti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-9486","authenticated-orcid":false,"given":"Benjamin","family":"Renaud-Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3412-2298","authenticated-orcid":false,"given":"Mitsuaki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fernandez-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2611-5928","authenticated-orcid":false,"given":"Eyal","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Dianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-8094","authenticated-orcid":false,"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne G.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Tikkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9234-6807","authenticated-orcid":false,"given":"Tereza","family":"Martinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2023.03.009_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.healun.2013.10.022","article-title":"A new classification system for chronic lung allograft dysfunction","volume":"33","author":"Verleden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0003","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction","volume":"30","author":"Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2020.04.012","article-title":"Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system","volume":"39","author":"Levy","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2008.104133","article-title":"Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation","volume":"64","author":"Borthwick","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2023.03.009_bib0006","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1111\/j.1600-6143.2012.04201.x","article-title":"Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation","volume":"12","author":"Kelly","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chest.2016.04.014","article-title":"Advances in understanding bronchiolitis obliterans after lung transplantation","volume":"150","author":"Verleden","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.healun.2023.03.009_bib0008","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/thx.2005.043026","article-title":"Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients","volume":"60","author":"Ward","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2023.03.009_bib0009","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0033-1348467","article-title":"Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation","volume":"34","author":"Weigt","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/tri.13444","article-title":"Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study","volume":"32","author":"Levy","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2023.03.009_bib0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1165\/rcmb.2005-0436SF","article-title":"Airway mucus: from production to secretion","volume":"34","author":"Williams","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2023.03.009_bib0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"American Thoracic S, European Respiratory S, American College of Chest P: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0013","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.02.00081102","article-title":"Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis","volume":"19","author":"Greene","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2023.03.009_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00003246-200301000-00003","article-title":"Prognostic value of surfactant proteins A and D in patients with acute lung injury","volume":"31","author":"Cheng","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0015","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1378\/chest.08-2465","article-title":"Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury","volume":"135","author":"Kropski","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.healun.2023.03.009_bib0016","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/00007890-200204270-00013","article-title":"Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients","volume":"73","author":"Nord","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2023.03.009_bib0017","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2020.04.012","article-title":"Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system","volume":"39","author":"Levy","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajt.15561","article-title":"The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation","volume":"20","author":"Levy","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0019","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.healun.2020.07.006","article-title":"International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation","volume":"39","author":"Martinu","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.03.009_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","article-title":"Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites","volume":"226","author":"Saenz","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.healun.2023.03.009_bib0022","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1513\/pats.200805-041HR","article-title":"Airway epithelial cells: current concepts and challenges","volume":"5","author":"Crystal","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.healun.2023.03.009_bib0023","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI45961","article-title":"The three R's of lung health and disease: repair, remodeling, and regeneration","volume":"121","author":"Beers","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2023.03.009_bib0024","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1183\/09031936.00069307","article-title":"Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?","volume":"30","author":"Maher","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2023.03.009_bib0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bbabio.2006.06.014","article-title":"Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response","volume":"1757","author":"Festjens","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.healun.2023.03.009_bib0026","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jim-2018-000785","article-title":"The characteristics and clinical significance of mucin levels in bronchoalveolar lavage fluid of patients with interstitial lung disease","volume":"67","author":"Wei","year":"2019","journal-title":"J Investig Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0027","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0028","doi-asserted-by":"crossref","first-page":"287","DOI":"10.21037\/jtd.2017.02.14","article-title":"Serum KL-6 in pulmonary alveolar proteinosis: China compared historically with Germany and Japan","volume":"9","author":"Guo","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2023.03.009_bib0029","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/ajrccm.158.4.9712003","article-title":"Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis","volume":"158","author":"Takahashi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","article-title":"Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis","volume":"11","author":"Yokoyama","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.healun.2023.03.009_bib0031","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.healun.2023.03.009_bib0032","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2023.03.009_bib0033","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2023.03.009_bib0034","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2003.12.043","article-title":"The predictive and prognostic value of serum CA 125 half-life during paclitaxel\/platinum-based chemotherapy in patients with advanced ovarian carcinoma","volume":"93","author":"Gadducci","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.healun.2023.03.009_bib0035","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.7314\/APJCP.2013.14.6.3937","article-title":"Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer","volume":"14","author":"Zhang","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.healun.2023.03.009_bib0036","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cllc.2011.03.019","article-title":"Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC)","volume":"12","author":"Cedres","year":"2011","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.healun.2023.03.009_bib0037","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5468\/ogs.2013.56.5.281","article-title":"Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: the Asian experience 2000 to 2012","volume":"56","author":"Patsner","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.healun.2023.03.009_bib0038","first-page":"145","article-title":"Preoperative serum tumor marker levels in gastric cancer","volume":"30","author":"Polat","year":"2014","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.healun.2023.03.009_bib0039","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.chest.2017.05.018","article-title":"CA-125 in disease progression and treatment of lymphangioleiomyomatosis","volume":"153","author":"Glasgow","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.healun.2023.03.009_bib0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tube.2012.10.014","article-title":"The clinical significance of CA-125 in pulmonary tuberculosis","volume":"93","author":"Kim","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.healun.2023.03.009_bib0041","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-6147(00)01600-X","article-title":"Airway goblet-cell mucus secretion","volume":"22","author":"Jackson","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.healun.2023.03.009_bib0042","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0925-4439(98)00060-X","article-title":"Pulmonary surfactant: functions and molecular composition","volume":"1408","author":"Goerke","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.healun.2023.03.009_bib0043","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/modpathol.2012.171","article-title":"Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis","volume":"26","author":"Ofek","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.healun.2023.03.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0050-2021","article-title":"Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review","volume":"30","author":"Bos","year":"2021","journal-title":"Eur Respir Rev"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823017874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823017874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:03:22Z","timestamp":1778796202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249823017874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1053249823017874"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2023.03.009","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}